Loading, Please Wait...

CST: 27/05/2019 01:00:02   

The Greater Cannabis Company Announces Uplisting To New Market Tier

88 Days ago

CEO discusses access to institutional investors, increased transparency, and best practice corporate governance

Baltimore, MD, Feb. 27, 2019 (GLOBE NEWSWIRE) -- The Greater Cannabis Company, Inc. (OTC: GCAN) (“the Company”), a biopharmaceutical company focused on development and commercialization of innovative delivery systems for the Cannabis market, today announced that shares of its common stock were approved for quotation on the OTCQB® Venture Market. To qualify for this market, companies must meet high financial standards, follow best practice corporate governance, demonstrate compliance with U.S. securities laws and be current in their disclosure. The Company believes that the move to the OTCQB will provide enhanced investor benefits including higher reporting standards, greater access to analyst coverage and news services, and more comprehensive compliance requirements. The OTCQB is considered by the Securities and Exchange Commission (SEC) as an “established public market” for the purpose of determining the public market price when registering securities for resale with the SEC. The OTCQB dramatically increases transparency, reporting standards, management certification and compliance requirements. The majority of broker dealers trade stocks on the OTCQB. Historically this has resulted in greater liquidity and awareness for companies that reach the OTCQB tier.

"Since going public we have focused on enhancing transparency and implementing best practice corporate governance. Upgrading from the Pink Market Tier to the OTCQB is the next logical step in our strategy as we work to unlock and maximize shareholder value”, stated Aitan Zacharin, CEO of Greater Cannabis.  “Our decision to move to the OTCQB® Venture Market reflects the building interest in our story and will allow us to increase our exposure to the investment community, both in the US and internationally.” “We anticipate that trading on the OTCQB will not only help in increasing our shareholder base, but will also raise visibility with institutional investors, which historically do not invest in Pink Sheet companies. We are excited to increase liquidity and transparency for our shareholders through an established and respected platform.”

To learn more, visit OTCQB. U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the Company on www.otcmarkets.com.

About The Greater Cannabis Company:
The Greater Cannabis is a biopharmaceutical company focused on the development and commercialization of innovative cannabinoid delivery systems. Greater Cannabis deploys its patented technology platform for use in the cannabis industry. The Company’s conveyance platform can be utilized to deliver cannabinoids without the harmful side effects found with other routes of cannabinoid administration. The technology is versatile in that for the first-time patients can receive lower dosing, enhanced bioavailability, and controlled rapid and delayed release using a fully dissolvable, non-irritant oral eluting patch. Greater Cannabis’ mission is to bring our technology to the global market through partnerships with leading cannabis and pharmaceutical companies, for the benefit of patients and consumers. More information on the Greater Cannabis Company and its technology can be found on the Company’s website, www.gcanrx.com.

Forward Looking Statements and Disclaimer:

Statements made in this press release that express the Company or management's intentions, plans, beliefs, expectations or predictions of future events, are forward-looking statements. The words "believe," "expect," "intend," "estimate," "anticipate," "will" and similar expressions are intended to further identify such forward-looking statements, although not all forward-looking statements contain these identifying words. Those statements are based on many assumptions and are subject to many known and unknown risks, uncertainties and other factors that could cause the Company's actual activities, results or performance to differ materially from those anticipated or projected in such forward-looking statements. The Company cannot guarantee future financial results; levels of activity, performance or achievements and investors should not place undue reliance on the Company's forward-looking statements. No information contained in this press release should be construed as any indication whatsoever of the Company's future financial performance, future revenues or its future stock price. The forward-looking statements contained herein represent the judgment of the Company as of the date of this press release, and the Company expressly disclaims any intent, obligation or undertaking to update or revise such forward-looking statements to reflect any change in the Company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based. No information in this press release should be construed as any indication whatsoever of the Company's future revenues or results of operations. Additional risks and uncertainties are set forth in the Company's Annual Report for the year ended December 31, 2017, filed with the Securities and Exchange Commission and available at www.sec.gov.

Contact:

The Greater Cannabis Company, Inc.
443-738-4051
info@gcanrx.com
www.gcanrx.com 


Is your business listed correctly on America’s largest city directory network of 1,000 portals?